These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 12846754)

  • 1. Lithium-induced nephropathy: Rate of progression and prognostic factors.
    Presne C; Fakhouri F; Noël LH; Stengel B; Even C; Kreis H; Mignon F; Grünfeld JP
    Kidney Int; 2003 Aug; 64(2):585-92. PubMed ID: 12846754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Renal side effects of long-term lithium therapy].
    Ibbeken C; Becker JU; Baumgärtel MW
    Dtsch Med Wochenschr; 2012 Jan; 137(4):143-8. PubMed ID: 22259170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Impaired kidney function in lithium therapy].
    Gabutti L; Gugger M; Marti HP
    Ther Umsch; 1998 Sep; 55(9):562-4. PubMed ID: 9789472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Progressive renal failure caused by lithium nephropathy].
    Presne C; Fakhouri F; Kenouch S; Stengel B; Kreis H; Grünfeld JP
    Presse Med; 2002 May; 31(18):828-33. PubMed ID: 12148451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dyslipidaemia and the progression of renal disease in chronic renal failure patients.
    Massy ZA; Nguyen Khoa T; Lacour B; Descamps-Latscha B; Man NK; Jungers P
    Nephrol Dial Transplant; 1999 Oct; 14(10):2392-7. PubMed ID: 10528663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. End-stage renal disease associated with prophylactic lithium treatment.
    Aiff H; Attman PO; Aurell M; Bendz H; Schön S; Svedlund J
    Eur Neuropsychopharmacol; 2014 Apr; 24(4):540-4. PubMed ID: 24503277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The pathomorphology and pathogenesis of lithium-induced nephropathy].
    Pospishil' IuO
    Lik Sprava; 1998 Jun; (4):72-4. PubMed ID: 9784708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Presentation, prognosis and outcome of IgA nephropathy in Indian adults.
    Chacko B; John GT; Neelakantan N; Korula A; Balakrishnan N; Kirubakaran MG; Jacob CK
    Nephrology (Carlton); 2005 Oct; 10(5):496-503. PubMed ID: 16221102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lithium nephrotoxicity: a progressive combined glomerular and tubulointerstitial nephropathy.
    Markowitz GS; Radhakrishnan J; Kambham N; Valeri AM; Hines WH; D'Agati VD
    J Am Soc Nephrol; 2000 Aug; 11(8):1439-1448. PubMed ID: 10906157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Important hypercalcaemia due to hyperparathyroidism induced by lithium].
    Lions C; Precloux P; Burckard E; Soubirou JL; Escarment J
    Ann Fr Anesth Reanim; 2005 Mar; 24(3):270-3. PubMed ID: 15792560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic factors and therapy assessment of IgA nephropathy: report from a single unit in iran.
    Soleymanian T; Najafi I; Salimi BH; Broomand B
    Ren Fail; 2011; 33(6):572-7. PubMed ID: 21663387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors predicting progression of IgA nephropathies.
    Coppo R; D'Amico G
    J Nephrol; 2005; 18(5):503-12. PubMed ID: 16299675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The effect of long-term lithium treatment on kidney function].
    Rybakowski J; Drogowska J; Abramowicz M; Chłopocka-Woźniak M; Czekalski S
    Psychiatr Pol; 2012; 46(4):627-36. PubMed ID: 23214164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical, biochemical and pathological predictors of poor response to intravenous cyclophosphamide in patients with proliferative lupus nephritis.
    Conlon PJ; Fischer CA; Levesque MC; Smith SR; St Clair EW; Allen NB; Fleming JA; Howell DN
    Clin Nephrol; 1996 Sep; 46(3):170-5. PubMed ID: 8879851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased risk of solid renal tumors in lithium-treated patients.
    Zaidan M; Stucker F; Stengel B; Vasiliu V; Hummel A; Landais P; Boffa JJ; Ronco P; Grünfeld JP; Servais A
    Kidney Int; 2014 Jul; 86(1):184-90. PubMed ID: 24451323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical prognostic factors in lupus nephritis. The importance of hypertension and smoking.
    Ward MM; Studenski S
    Arch Intern Med; 1992 Oct; 152(10):2082-8. PubMed ID: 1417382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of concomitant hepatitis C virus infection in patients with underlying lupus nephritis on long-term renal outcome.
    Mitwalli AH; Hayat A; Alwakeel J; Hammad D
    Nephrol Dial Transplant; 2012 Feb; 27(2):627-32. PubMed ID: 21771749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors of renal failure progression two years prior to dialysis.
    Mazouz H; Kacso I; Ghazali A; El Esper N; Moriniere P; Makdassi R; Hardy P; Westeel PF; Achard JM; Pruna A; Fournier A
    Clin Nephrol; 1999 Jun; 51(6):355-66. PubMed ID: 10404696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [An analysis of the clinical and pathological characteristics of mu-tong (a Chinese herb) induced tubulointerstitial nephropathy].
    Li X; Yang L; Yu Y
    Zhonghua Nei Ke Za Zhi; 2001 Oct; 40(10):681-7. PubMed ID: 11769723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term effects of lithium on renal, thyroid, and parathyroid function: a retrospective analysis of laboratory data.
    Shine B; McKnight RF; Leaver L; Geddes JR
    Lancet; 2015 Aug; 386(9992):461-8. PubMed ID: 26003379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.